Dr. Jakub Malcher is a forward-thinking Program and Operations Manager at Bayer Co.Lab Berlin, an incubator and accelerator dedicated to nurturing start-ups in the gene and cell therapy space. With a strong foundation as a molecular biologist in pre-clinical development at Bayer, he specializes in pioneering viral delivery systems. His recent work focused on developing tissue-specific adeno-associated viruses (AAVs) for groundbreaking gene therapy applications. Jakub's expertise and passion for innovation drive transformative solutions in the biotech landscape.